The majority of people say it is important for them to achieve their optimum wellbeing, yet only 1 in 2 people are satisfied with their current levels of wellbeing. As this is not just about “feeling good” – wellbeing has been demonstrated to add years to life and improve recovery from illness – the wellbeing gap has significant implications for treatment decisions and costs.
So how can wellbeing be leveraged for sustainable health policy?
We are excited to fuel this discussion with the launch of the Edelman Wellbeing Index, the first study of its kind that measures attitudes towards and dimensions of wellbeing across Europe.
Closely linked to the discussion on wellbeing, are the findings from this year’s Trust Barometer, which heralds a new trend for health: despite a decrease in trust across institutions broadly, the study found, for the first time ever, an increase in global trust across healthcare as an industry and across five sub-sectors. That being said, there still remains significant scope for improvement, as the following findings reveal:
-More than 7 in 10 consumers said they are confident in their own ability to find answers about healthcare and make informed decisions,
-8 in 10 agree government needs to do more to regulate the Pharmaceutical industry,
-Only 6 in 10 know the name of the company that produces their prescription medication.
Of note for the wellbeing of all of us in the Brussels bubble, the Trust data further shows that there are no regrets and the Brexit vote would be the same today.
Presentations by Gurpreet Brar, General Manager of Edelman Brussels, and Kajsa Wilhelmsson, Head of Health Policy & Market Access at A&R Edelman. To be followed by a discussion with representatives from patient groups, media and industry.